## LMT: Lockheed Martin Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 2.9% below STRENGTH zone (4.0-10.0%); PEG 1.56 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($463.55)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 2)

**1. JP Morgan Downgrades Lockheed Martin Corporation (LMT) Citing Cash Flow Concerns**
- Source: Insider Monkey | 20251223T165300 | Somewhat-Bearish | Relevance: 100%
- JP Morgan downgraded Lockheed Martin Corporation (NYSE: LMT) to Neutral from Overweight on December 19, citing concerns about the defense contractor's long-term cash flow estimates, particularly pension-related outflows. Morgan Stanley also adjusted its rating earlier to Equal Weight with a reduced price target. Despite these downgrades, Wall Street analysts have a consensus Hold rating for LMT with a 9% upside.

**2. JP Morgan Downgrades Lockheed Martin Corporation (LMT) Citing Cash Flow Concerns**
- Source: Finviz | 20251223T165300 | Somewhat-Bearish | Relevance: 100%
- JP Morgan has downgraded Lockheed Martin Corporation (LMT) to Neutral from Overweight due to concerns about the defense contractor's long-term cash flow estimates, specifically citing pension-related outflows expected next year. Despite this, JP Morgan raised its price target for LMT to $515, while Morgan Stanley also recently downgraded the stock and lowered its price target. Overall, Wall Street analysts currently hold a consensus Hold rating for LMT with a one-year average share price target of $524.93.

**3. Lockheed Martin awarded $1B contract to supply 18 satellites for Space Development Agency**
- Source: Homeland Preparedness News | 20251223T130820 | Bullish | Relevance: 100%
- Lockheed Martin has secured a contract worth over $1 billion from the Space Development Agency (SDA) to provide 18 satellites for the Tranche 3 Tracking Layer constellation. These satellites will enhance missile warning, tracking, and defense capabilities, specifically targeting conventional and advanced missile threats including hypersonic systems. The company's work on this project, which builds on a previous award, will contribute to SDA’s Proliferated Warfighter Space Architecture.

**4. Is Lockheed’s US$1 Billion SDA Satellite Award Altering The Investment Case For Lockheed Martin (LMT)?**
- Source: Simply Wall Street | 20251221T025006 | Bullish | Relevance: 100%
- Lockheed Martin has been awarded a contract worth over US$1 billion by the Space Development Agency to build 18 advanced missile-warning and tracking satellites, increasing its total SDA satellite count to 124. This award strengthens Lockheed's position in next-generation missile defense space infrastructure and supports its space segment growth and missile warning capabilities. However, it doesn't fundamentally change the investment risk associated with cost and execution pressures on complex, fixed-price programs.

**5. US watchdog says F-35s flew half the time in 2024 due to Lockheed maintenance issues**
- Source: Reuters | 20251223T214513 | Somewhat-Bearish | Relevance: 100%
- A U.S. watchdog report states that F-35 fighter jets were only available to fly half the time in 2024, falling 17% short of minimum performance requirements, due to maintenance issues by Lockheed Martin. The Pentagon's Office of the Inspector General criticized the lack of accountability for Lockheed Martin's poor performance and identified that the Pentagon paid the company $1.7 billion without economic adjustment despite the aircraft's unavailability. Lockheed Martin has not yet commented on the report.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | JP Morgan | $515 | $465 | +11% |
| 2025-12-16 | Morgan Stanley | $543 | $630 | -14% |
| 2025-12-12 | Citigroup | $505 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | JP Morgan | down | Neutral |
| 2025-12-16 | Morgan Stanley | down | Equal-Weight |
| 2025-12-12 | Citigroup | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.00M) |
| Sells | 7 ($1.59M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- State Street Corpora: 14.8% (-1.0%)
- Vanguard Group Inc: 9.2% (-1.9%)
- Blackrock Inc.: 7.3% (-2.4%)
- Charles Schwab Inves: 3.7% (+8.6%)
- Morgan Stanley: 2.2% (-2.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.56 elevated, pricing in significant growth expectations. Forward P/E 16.5x attractive for 31% earnings growth. Quality metrics strong (ROE 63%). Balance sheet: $3.3B free cash flow. Insider selling cluster ($1.6M in 90 days), potential headwind. Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $112.7B |
| Beta | 0.24 |
| 52W Range | $410.11 - $516.00 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.56 |
| Forward P/E | 16.5 |
| Current P/E | 21.7 |
| YoY Growth | 31.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 5.2% to 2.9% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.1pp (needs >4.0% for momentum thesis). MRS_5 (-0.4%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 4.0% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.62), confirming momentum. RSI neutral at 60. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.90% (CS: 81) | Neutral |
| RSI_14 | 59.6 | Neutral |
| MACD Histogram | 2.62 | Bullish |
| vs SMA20 | 1.038x | Above |
| vs SMA50 | 1.021x | Above |
| vs SMA200 | 1.037x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $482.53
- **Stop Loss:** $463.55 (3.9% risk)
- **Target:** $501.51 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 47
- **Position Value:** $22,678.91
- **Portfolio %:** 22.68%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-27 (Est: $6.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.35 | $6.95 | +9.4% |
| 2025Q2 | $6.47 | $1.46 | -77.4% |
| 2025Q1 | $6.32 | $7.28 | +15.1% |
| 2024Q4 | $6.62 | $7.71 | +16.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*